As INK4a/ARF loss is central to the oncogenesis of MPNST, these functional interactions with FOXM1 suggest that FOXM1 may also be an important driver in this cancer (Figure 2). The gene discussed is CDKN2A; the disease is malignant peripheral nerve sheath tumor.